Home › Stocks › VRXA › Changes
Who bought & sold VRXA (Q2 2026)
Funds holding (Q2 2026)9
New positions9
Added0
Reduced0
Exited0
As of Q2 2026, 9 institutional funds reported holding VRXA (Veraxa Biotech AG): 9 opened new positions, 0 added, 0 trimmed and 0 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.
New positions (9)
| Fund | Shares | Value | Weight |
|---|---|---|---|
| UBS Group AG New | 157.24K | $295.61K | — |
| GEODE CAPITAL MANAGEMENT, LLC New | 119.77K | $225.16K | — |
| Geode Capital Management New | 119.77K | $225.16K | — |
| HRT FINANCIAL LP New | 18.87K | $35.00K | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP New | 10.83K | $20.37K | — |
| PICTON MAHONEY ASSET MANAGEMENT New | 175.00K | $19.30K | — |
| WOLVERINE ASSET MANAGEMENT LLC New | 1.75K | $3.29K | — |
| JPMorgan Chase & Co New | 396 | $859 | — |
| Caitong International Asset Management Co., Ltd New | 6 | $11 | — |
Added to positions (0)
No adds this quarter.
Reduced positions (0)
No trims this quarter.
Exited positions (0)
No exits this quarter.